News
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...
A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...
Leaders at Merck & Co. Inc. are facing a new derivative shareholder lawsuit over allegations that they made misleading ...
Merck is holding strong among billionaire favorites, despite the broader healthcare sector dodging investor affection like a ...
2h
Barchart on MSNWhat to Expect From Merck & Co.'s Next Quarterly Earnings ReportRahway, New Jersey-based Merck & Co., Inc. (MRK) functions as a healthcare company. Valued at $200 billion by market cap, the ...
On July 30, 2024, Merck released its second quarter 2024 financial report and disclosed a significant reduction in Gardasil vaccinations, resulting in an overabundance of inventory at Merck's Chinese ...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Merck & Co., Inc. ("Merck" or "the Company") for violations of §§10(b) and 20(a ...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims On Behalf Of Investors Of Merck & Co.
Defendants' statements included, among other things, confidence in Merck's purported ability to utilize successful consumer activation and education efforts on the benefits of Gardasil in order to ...
CASE DETAILS: According to the complaint, defendants provided investors with material information concerning Merck's expected revenue of $11 billion from sales of Gardasil by 2030. Defendants ...
While artificial intelligence (AI) and data analytics have already made significant inroads in clinical diagnostics, their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results